AbbVie Inc. | Ownership

Companies that own AbbVie Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Capital Research & Management Co. (Global Investors)
193,768,855
12.8%
686,114
3.38%
06/30/2018
The Vanguard Group, Inc.
115,510,387
7.63%
-3,391,202
0.36%
06/30/2018
BlackRock Fund Advisors
66,830,862
4.41%
-5,828,299
0.32%
06/30/2018
SSgA Funds Management, Inc.
60,801,253
4.01%
-2,794,830
0.44%
06/30/2018
Northern Trust Investments, Inc.
21,331,676
1.41%
-321,093
0.46%
06/30/2018
Geode Capital Management LLC
16,665,619
1.1%
-494,832
0.4%
06/30/2018
Orbis Investment Management Ltd.
14,689,252
0.97%
1,203,008
5.19%
06/30/2018
Capital Research & Management Co. (World Investors)
14,500,593
0.96%
-2,603,223
0.2%
06/30/2018
Norges Bank Investment Management
13,795,344
0.91%
588,618
0.19%
12/31/2017
Arrowstreet Capital LP
11,980,294
0.79%
3,763,730
2.49%
06/30/2018

About AbbVie

View Profile
Address
1 North Waukegan Road
North Chicago Illinois 60064
United States
Employees -
Website http://www.abbvie.com
Updated 07/08/2019
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.